A Study to Evaluate the Drug Levels of Cendakimab Delivered Subcutaneously in Healthy Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to evaluate the drug levels of cendakimab delivered subcutaneously in healthy participants.
Epistemonikos ID: 1b1e09a7ffc42c56a3101bf945329f8b031cec21
First added on: May 13, 2024